In a patient with placenta previa needing short‑term tocolysis for antenatal corticosteroids, how do terbutaline and nifedipine compare regarding first‑line choice, dosing, contraindications, and monitoring?

Terbutaline vs Nifedipine for Short-Term Tocolysis in Placenta Previa

Neither terbutaline nor nifedipine should be considered first-line tocolysis in placenta previa, as the highest quality evidence shows nifedipine provides no benefit over placebo in this specific population, and tocolysis should only be used for 48 hours to facilitate corticosteroid administration—not to prolong pregnancy. 1, 2

First-Line Choice: Neither is Ideal, But Use Tocolysis Only for Steroid Coverage

The 2019 RCOG guideline explicitly states that tocolysis may be considered for 48 hours to facilitate administration of antenatal corticosteroids in symptomatic placenta previa 1. Critically, the guideline emphasizes that if delivery is indicated based on maternal or fetal concerns, tocolysis should not be used in an attempt to prolong gestation 1.

The Evidence Against Nifedipine in Placenta Previa

A 2017 randomized, double-blind, placebo-controlled multicenter trial (n=109) specifically studied women with placenta previa bleeding at 24-34 weeks. Nifedipine showed no difference in pregnancy prolongation compared to placebo (42.5 vs 44.2 days, p=0.70), and cesarean delivery due to hemorrhage before 37 weeks occurred MORE frequently with nifedipine (RR 1.66,95% CI 1.05-2.72) 2. This is the most recent, highest-quality evidence directly addressing your question, and it demonstrates nifedipine is ineffective in this specific population.

The RCOG guideline references this same trial, noting "there was no difference in the prolongation of pregnancy between the nifedipine and placebo groups. Adverse perinatal outcomes were comparable between groups" 1.

What About Terbutaline?

While no placenta previa-specific RCT exists for terbutaline, general preterm labor studies show:

• Terbutaline and nifedipine have equivalent tocolytic efficacy in standard preterm labor (not placenta previa) 3, 4, 5, 6
• Terbutaline causes significantly more maternal side effects: tremor (76.4% vs 0%), nausea (58.8% vs 9.4%), dizziness (29.4% vs 6.25%), and increased maternal heart rate 3, 5
• Nifedipine causes more flushing (43.7% vs 2.94%) and headache (31.2% vs 5.9%) but overall fewer total adverse effects 3

Practical Algorithm for Placenta Previa with Bleeding

Step 1: Assess if tocolysis is appropriate

• Is the goal to give corticosteroids? → Consider 48-hour tocolysis
• Is there maternal hemorrhage requiring delivery? → NO tocolysis 1
• Is there fetal distress? → NO tocolysis 1

Step 2: If 48-hour tocolysis is appropriate, choose based on contraindications

Use subcutaneous terbutaline 0.25 mg if:

• No maternal cardiac disease
• No maternal hyperthyroidism
• No maternal diabetes (relative)
• Patient can tolerate tremor and tachycardia

Use oral nifedipine 10-20 mg if:

• Maternal cardiac contraindications to beta-agonists exist
• Patient preference for oral route
• BUT recognize it may not work better than placebo in placenta previa 2

Dosing Regimens

Terbutaline (Off-Label for Tocolysis)

• Subcutaneous: 0.25 mg every 4 hours for up to 48 hours 7, 8
• WARNING: FDA contraindication for oral terbutaline in tocolysis 7
• For acute intrauterine resuscitation: 250 mcg subcutaneous as single dose 8

Nifedipine (Off-Label for Tocolysis)

• Loading: 10-20 mg orally, may repeat every 20 minutes (maximum 40 mg in first hour) 5
• Maintenance: 20 mg orally every 4-6 hours for up to 48 hours 5
• Must be swallowed whole if using extended-release formulation 9
• Avoid grapefruit juice (CYP3A interaction) 9

Contraindications

Terbutaline - Absolute Contraindications:

• Hypersensitivity to sympathomimetics 7
• Maternal cardiac arrhythmias or significant cardiac disease
• Uncontrolled hyperthyroidism
• Oral formulation for any tocolysis 7

Nifedipine - Absolute Contraindications:

• Maternal hypotension (systolic BP <90 mmHg)
• Concurrent use with strong CYP3A inducers (rifampin) 9
• Severe hepatic impairment (use lowest dose with caution) 9

Nifedipine - Relative Contraindications/Cautions:

• Concurrent magnesium sulfate (risk of severe hypotension and neuromuscular blockade)
• Concurrent beta-blockers (may increase risk of heart failure or severe hypotension) 9
• Concurrent CYP3A inhibitors (ketoconazole, clarithromycin, erythromycin, grapefruit) - require dose reduction 9

Monitoring Requirements

For Terbutaline:

• Maternal heart rate and blood pressure every 15-30 minutes during initial dosing
• Continuous fetal heart rate monitoring
• Monitor for pulmonary edema (rare but serious)
• Assess glucose in diabetic patients

For Nifedipine:

• Maternal blood pressure every 15-30 minutes for first 1-2 hours
• Maternal heart rate monitoring
• Continuous fetal heart rate monitoring
• Less effect on fetal heart rate compared to terbutaline 4

Critical Caveats

1. The goal is NOT pregnancy prolongation in placenta previa - it's steroid administration 1, 2

2. Active hemorrhage is a contraindication to tocolysis - if the mother is bleeding significantly enough to require delivery, do not delay 1

3. Nifedipine specifically does not work in placenta previa based on the best available RCT 2

4. Terbutaline has more systemic side effects but may be more appropriate for the 48-hour window needed for steroids 3

5. Consider no tocolysis at all - the placebo-controlled trial suggests expectant management may be equally appropriate 2